INVESTIGATION OF BMI, ETC CHANGES FOLLOWING A SWITCH FROM OLANZAPINE

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 中心，不一定是研究者的机构。 通过这项研究，我们希望了解阿立哌唑是否可以逆转体重增加以及人们服用奥氮平，利培酮或奎替利时出现的高血糖，血脂或血压问题。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. With this study, we hope to find out if aripiprazole can reverse weight gain and problems with high blood sugar, lipids or blood pressure that have developed while people have been taking olanzapine, resperidone or quetiapine.